Skip to main content

Table 5 Treatment-related adverse events

From: Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

Symptom CTCAE v4.0
Any grade Grade 1 Grade 2
No. % No. % No. %
Dry mouth 69 49.3 66 47.1 3 2.1
Hiccups 47 33.6 42 30.0 5 3.6
Constipation 97 69.3 69 49.3 28 20.0
Dizziness 41 29.3 41 29.3 0 0.0
Insomnia 62 44.3 58 41.4 4 2.9
Somnolence 96 68.6 92 65.7 4 2.9
  1. CTCAE v4.0 Common Terminology Criteria for Adverse Events version 4.0.